nach oben

Erschienen in:

20.07.2021 | Original Article

Efficacy and safety of laser combination therapy and laser alone therapy for keloid: a systematic review and meta-analysis

verfasst von: Jiahui Chen, Aiyue Chen, Jianhao Zhang, Feipeng Wang, Qiongfang Fang, Ziwei He, Xi Chen, Wancheng Ma, Fulan Hu

Erschienen in: Lasers in Medical Science | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the efficacy and safety of laser alone therapy and laser combination therapy (mainly combined with other kinds of laser or steroids) for keloid.

PubMed, Embase and Web of Science were searched for relevant articles from inception to June 2020. Comprehensive Meta-Analysis software 2.0 (CMA) was used to perform the meta-analysis.

A total of 29 articles were included in this meta-analysis. During the mean follow-up of 14 (1–84) months, the overall improvement rates of baseline Vancouver scar scale (VSS) score and itch were 0.454 (95%CI 0.351–0.561, I² = 0) and 0.786 (95%CI 0.613–0.895, I² = 0) in the laser combination therapy group. The improvement rates of scar height and flexibility in the laser combination therapy group were 0.629 (95%CI 0.519–0.727, I² = 52.089) and 0.784 (95%CI 0.251–0.975, I² = 89.420). The average improvement rate of the scar score in laser combination therapy was 0.338 (0.201–0.510); however, there were insufficient data for laser alone therapy comparison. The laser combination therapy had a greater pain improvement rate, 0.580 (0.389–0.750) versus 0.420 (0.224–0.645), compared to laser alone therapy, and a greater degree of good or excellent (> 50%) improvement in the overall scar, 0.636 (95%CI 0.347–0.852) versus 0.149 (95%CI 0.032–0.482), with laser alone therapy. Moreover, a lower regrowth rate of 0.187 (0.129–0.263) versus 0.249 (0.060–0.631), a lower post-treatment pigmentation rate of 0.125 (0.091–0.169) versus 0.135 (0.058–0.282), and a lower infection rate of 0.047 (0.009–0.209) versus 0.076 (0.012–0.351) were observed in the laser combination therapy compared with those rates in the laser alone therapy.

The overall effect of laser combination therapy was better than that of laser alone therapy, and the incidence of adverse reactions was lower in laser combination therapy than in laser alone therapy.

Nur mit Berechtigung zugänglich

Huang C, Murphy GF, Akaishi S, Ogawa R (2013) Keloids and Hypertrophic Scars: Update and Future Directions. Plast Reconstr Surg Glob Open 1(4):e25. https://doi.org/10.1097/GOX.0b013e31829c4597CrossRefPubMedPubMedCentral

Ogawa R (2011) Mechanobiology of scarring. Wound Repair Regen 19(Supplement s1):s2–s9PubMed

Slemp AE, Kirschner RE (2006) Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 18(4):396–402PubMed

Connell PG, Harland CC (2000) Treatment of keloid scars with pulsed dye laser and intralesional steroid. J Cutan Laser Ther 2(3):147–150PubMed

Hochman B, Locali RF, Matsuoka PK, Ferreira LM (2008) Intralesional triamcinolone acetonide for keloid treatment: a systematic review. Aesthetic Plast Surg 32(4):705–709PubMed

Mustoe TA, Cooter RD, Gold MH, Hobbs FDR, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UEJP et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110(2):560PubMed

Beigvand HH, Razzaghi MR, Rostami-Nejad M, Rezaei-Tavirani M, Safari S, Rezaei-Tavirani M, Mansouri V, Heidari MH (2020) Assessment of laser effects on skin rejuvenation. J Lasers Med Sci 11(2):212–219

Khansa I, Harrison B, Janis JE (2016) Evidence-Based Scar Management: How to Improve Results with Technique and Technology. Plast Reconstr Surg 138:165S-178S. https://doi.org/10.1097/PRS.0000000000002647CrossRefPubMed

Henning JPH, Roskam Y, Vangemert MJC (1986) Treatment of keloids and hypertrofic scars with an argon-laser. Lasers Surg Med 6(1):72–75

10.

Bonnardeaux E, McCuaig C (2020) Surgical excision combined with fully ablative carbon dioxide laser therapy and triamcinolone injections as a potential treatment for keloids in children. Pediatr Dermatol 37(1):137–141PubMed

11.

Kantor GR, Wheeland RG, Bailin PL (1985) Treatment of earlobe keloids with carbon dioxide laser excision: a report of 16 cases. J Dermatol Surg Oncol 11(11):1063–1067PubMed

12.

Stern JC, Lucente FE (1989) Carbon-dioxide laser excision of earlobe keloids - a prospective-study and critical analysis of existing data. Arch Otolaryngol Head Neck Surg 115(9):1107–1111PubMed

13.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 3(3):e123-130PubMedPubMedCentral

14.

Abergel RP, Dwyer RM, Meeker CA, Lask G, Kelly AP, Uitto J (1984) Laser treatment of keloids: a clinical trial and an in vitro study with Nd:YAG laser. Lasers Surg Med 4(3):291–295PubMed

15.

Apfelberg DB, Maser MR, Lash H, White D, Weston J (1984) Preliminary-results of argon and carbon-dioxide laser treatment of keloid scars. Lasers Surg Med 4(3):283–290PubMed

16.

Sherman R, Rosenfeld H (1988) Experience with the Nd:YAG laser in the treatment of keloid scars. Ann Plast Surg 21(3):231–235PubMed

17.

Norris JEC (1991) The effect of carbon-dioxide laser-surgery on the recurrence of keloids. Plast Reconstr Surg 87(1):44–49PubMed

18.

Kumar K, Kapoor BS, Rai P, Shukla HS (2000) In-situ irradiation of keloid scars with Nd:YAG laser. J Wound Care 9(5):213–215PubMed

19.

Paquet P, Hermanns JF, Pierard GE (2001) Effect of the 585 nm flashlamp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg 27(2):171–174PubMed

20.

Annabathula A, Sekar CS, Srinivas CR (2017) Fractional carbon dioxide, long pulse Nd:YAG and pulsed dye laser in the management of keloids. J Cutan Aesthet Surg 10(2):76–80PubMedPubMedCentral

21.

Azzam OA, Bassiouny DA, El-Hawary MS, El Maadawi ZM, Sobhi RM, El-Mesidy MS (2016) Treatment of hypertrophic scars and keloids by fractional carbon dioxide laser: a clinical, histological, and immunohistochemical study. Lasers Med Sci 31(1):9–18PubMed

22.

Behera B, Kumari R, Mohan D, Malathi M (2016) Therapeutic efficacy of intralesional steroid with carbon dioxide laser versus with cryotherapy in treatment of keloids: a randomized controlled trial. Dermatol Surg 42(10):1188–1198PubMed

23.

Cavalie M, Sillard L, Montaudie H, Bahadoran P, Lacour J-P, Passeron T (2015) Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther 28(2):74–78PubMed

24.

Chen XE, Liu J, Bin Jameel AA, Valeska M, Zhang JA, Xu Y, Liu XW, Zhou H, Luo D, Zhou BR (2017) Combined effects of long-pulsed neodymium-yttrium-aluminum-garnet laser, diprospan and 5-fluorouracil in the treatment of keloid scars. Exp Ther Med 13(6):3607–3612PubMedPubMedCentral

25.

Khattab FM, Nasr M, Khashaba SA, Bessar H (2020) Combination of pulsed dye laser and verapamil in comparison with verapamil alone in the treatment of keloid. J Dermatol Treat 31(2):186–190

26.

Lee Y, Kim J, Lee W, Lee J (2019) Combined therapeutic strategies for keloid treatment. J Investig Dermatol 139(9):S234–S234

27.

Li K, Nicoli F, Xi WJ, Zhang Z, Cui C, Al-Mousawi A, Balzani A, Tong Y, Zhang Y (2019) The 1470 nm diode laser with an intralesional fiber device: a proposed solution for the treatment of inflamed and infected keloids. Burns Trauma 7:5

28.

Nicoletti G, De Francesco F, Mele CM, Cataldo C, Grella R, Brongo S, Accardo M, Ferraro GA, D’Andrea F (2013) Clinical and histologic effects from CO2 laser treatment of keloids. Lasers Med Sci 28(3):957–964PubMed

29.

Park JH, Chun JY, Lee JH (2017) Laser-assisted topical corticosteroid delivery for the treatment of keloids. Lasers Med Sci 32(3):601–608PubMed

30.

Rossi A, Lu R, Frey MK, Kubota T, Smith LA, Perez M (2013) The use of the 300 microsecond 1064nm Nd:YAG laser in the treatment of keloids. J Drugs Dermatol 12(11):1256–1262PubMed

31.

Son IP, Park KY, Kim B, Kim MN (2014) Pilot study of the efficacy of 578 nm Copper bromide laser combined with intralesional corticosteroid injection for treatment of keloids and hypertrophic scars. Ann Dermatol 26(2):156–161PubMedPubMedCentral

32.

Yan D, Zhao B, Yang H, Zhu B, Wang J (2014) A combination of nonoperative treatment modalities used for treatment of keloids. Dermatol Ther 27(1):48–51PubMed

33.

Srivastava S, Kumari H, Singh A (2019) Comparison of fractional CO2 laser, verapamil, and triamcinolone for the treatment of keloid. Adv Wound Care 8(1):7–13

34.

Garg GA, Sao PP, Khopkar US (2011) Effect of carbon dioxide laser ablation followed by intralesional steroids on keloids. J Cutan Aesthet Surg 4(1):2–6PubMedPubMedCentral

35.

Kassab AN, El Kharbotly A (2012) Management of ear lobule keloids using 980-nm diode laser. Eur Arch Otorhinolaryngol 269(2):419–423PubMed

36.

Scrimali L, Lomeo G, Nolfo C, Pompili G, Tamburino S, Catalani A, Sirago P, Perrotta RE (2010) Treatment of hypertrophic scars and keloids with a fractional CO2 laser: a personal experience. J Cosmet Laser Ther 12(5):218–221PubMed

37.

Yencha MW, Oberman JP (2006) Combined therapy in the treatment of auricular keloids. Ear Nose Throat J 85(2):93–94 96–97PubMed

38.

Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic Scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17(1–2):113–125PubMed

39.

Berman B, Bieley HC (1996) Adjunct therapies to surgical management of keloids. Dermatol Surg 22(2):126–130PubMed

40.

Ogawa R, Okai K, Tokumura F, Mori K, Ohmori Y, Huang C, Hyakusoku H, Akaishi S (2012) The relationship between skin stretching/contraction and pathologic scarring: the important role of mechanical forces in keloid generation. Wound Repair Regen 20(2):149–157PubMed

41.

Hsu C-K, Lin H-H, Harn HI, Ogawa R, Wang Y-K, Ho Y-T, Chen W-R, Lee Y-C, Lee JY-Y, Shieh S-J et al (2018) Caveolin-1 controls hyperresponsiveness to mechanical stimuli and fibrogenesis-associated RUNX2 activation in keloid fibroblasts. J Investig Dermatol 138(1):208–218PubMed

42.

Glass DA (2017) Current understanding of the genetic causes of keloid formation. J Investig Dermatol Symp Proc 18(2):S50–S53PubMed

43.

Carroll LA, Hanasono MM, Mikulec AA, Kita M, Koch RJ (2002) Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts. Dermatol Surg 28(8):704–709PubMed

44.

Baryza MJ, Baryza GA (1995) The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil 16(5):535–538PubMed

45.

Stephanides S, Rai S, August P, Ferguson J, Madan V (2011) Treatment of refractory keloids with pulsed dye laser alone and with rotational pulsed dye laser and intralesional corticosteroids: A retrospective case series. Laser Ther 20(4):279–286PubMedPubMedCentral

Titel: Efficacy and safety of laser combination therapy and laser alone therapy for keloid: a systematic review and meta-analysis
verfasst von: Jiahui Chen
Aiyue Chen
Jianhao Zhang
Feipeng Wang
Qiongfang Fang
Ziwei He
Xi Chen
Wancheng Ma
Fulan Hu
Publikationsdatum: 20.07.2021
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 2/2022
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03364-4

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Transcutaneous systemic photobiomodulation reduced lung inflammation in experimental model of asthma by altering the mast cell degranulation and interleukin 10 level

Er:YAG laser-induced damage to a dental composite in simulated clinical scenarios for inadvertent irradiation: an in vitro study

Periocular rejuvenation using a unique non-ablative long-pulse 2940 nm Er:YAG laser

What else than eyes need special protectors during laser hair reduction sessions?

Comparison of picosecond versus nanosecond Nd:YAG lasers for the removal of cosmetic tattoos in an animal model

The application of SFDI and LSI system to evaluate the blood perfusion in skin flap mouse model